RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Clinical trial NCT03485118 · COMPLETED
Trial details
- NCT number
- NCT03485118
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-12
- Primary completion
- 2016-08-12
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.